Dr. Sattler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Po Box 4
West Point, PA 19486
Education & Training
Baylor College of MedicineFellowship, Pediatric Infectious Diseases, 1998 - 2001
Cayetano Heredia UniversityClass of 1992
Publications & Presentations
PubMed
- 1295 citationsQuadrivalent vaccine against human papillomavirus to prevent anogenital diseases.Suzanne M. Garland, Mauricio Hernández-Ávila, Cosette M. Wheeler, Gonzalo Perez, Diane M. Harper
The New England Journal of Medicine. 2007-05-10 - 133 citationsSafety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.Myron J. Levin, Anna-Barbara Moscicki, Lin-Ye Song, Terrence Fenton, William A. Meyer
Journal of Acquired Immune Deficiency Syndromes. 2010-10-01 - 333 citationsComparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in mal...Stan L. Block, Terry Nolan, Carlos Sattler, Eliav Barr, Katherine E.D. Giacoletti
Pediatrics. 2006-11-01
Authored Content
- Biosimilar Approval and Adoption in the U.S. Needs to Be ExpeditedMarch 2019
Press Mentions
Chutes & Ladders—Lonza Poaches Roche Vet Ruffieux as Newest CEOJune 11th, 2020
Biosimilar Approval and Adoption in the U.S. Needs to Be ExpeditedMarch 20th, 2019
The Center for Biosimilars® to Launch Biosimilars Stakeholders SummitNovember 12th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
